Scholars Central

ArticlePublished 1 Mar 2022

Monobactams as anticancers a review study

Authors: Ahmed AJ Mahmood

Systematic Reviews in Pharmacy

Volume 13 · Issue 3 · Pages 196–204

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Cancer is a heterogeneous disease which categories as the second-leading cause of death worldwide. It is fatal to 42% of diagnosed patient every year. The ideal anticancer agents needed to be powerful, well tolerated in patients, with low side effect and high selectivity. Antibiotics on the other hand are efficient, well tolerated, with very low level of toxicity. Therefore, they continue to be the most important goal for new drugs invention. 2-Azetidinones (β-lactams) are most marketing drugs than any other antibiotics. The β-lactams provide unlimited choices of biological activities, and they efficaciously used as anticancer agent’s delivery system directly to the tumor sites as pro-drugs. These records indicate that the designation and synthesis of new monobactams will be favorable zone for improvement anticancer studying researches.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Systematic Reviews in Pharmacy.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalSystematic Reviews in Pharmacy
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Ahmed AJ Mahmood”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels